<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/74A7A523-2885-41D6-97C6-2A62084E06EB"><gtr:id>74A7A523-2885-41D6-97C6-2A62084E06EB</gtr:id><gtr:name>ChromaDex</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/74A7A523-2885-41D6-97C6-2A62084E06EB"><gtr:id>74A7A523-2885-41D6-97C6-2A62084E06EB</gtr:id><gtr:name>ChromaDex</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0B900C40-33A8-4226-B5E8-272104FF850B"><gtr:id>0B900C40-33A8-4226-B5E8-272104FF850B</gtr:id><gtr:firstName>Gareth Geoffrey</gtr:firstName><gtr:surname>Lavery</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FG023468%2F1"><gtr:id>AD668D7A-63C9-47D5-BFB2-2A01E6C6B627</gtr:id><gtr:title>Investigating hexose-6-phosphate dehydrogenase in the control of skeletal muscle function and carbohydrate metabolism</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/G023468/1</gtr:grantReference><gtr:abstractText>This proposal aims to understand more about the metabolic pathways that mammals use to derive energy from the glucose found in food and utilise it in muscle. Muscle is a vital tissue for controlling body glucose levels, which when elevated can be detrimental. We currently live in a time when glucose and calorie rich food is widely available (the consequences of too much glucose and calories are seen in obesity and diabetes). However, the underlying biological consequences our changing diets has are poorly understood so it is becoming increasingly important to gain a better understanding of the fundamental physiological processes that regulate glucose and energy metabolism in muscle. Our recent work has identified two enzymes in muscle that control important aspects of glucose metabolism. The first enzyme called 11b-HSD1 controls steroid hormone levels, which have potent effects on glucose usage in response to stress. The second enzyme called H6PDH metabolises glucose. What is interesting is that H6PDH can control 11b-HSD1 depending upon the supply of glucose, however, steroid hormones can control glucose levels, highlighting that these enzymes can control each others functions. This interaction between glucose and steroid hormone metabolism is very novel and our recent preliminary findings indicate that it plays an important role, therefore we wish to explain the underlying biology in muscle. To achieve this, we will manipulate H6PDH and 11b-HSD1 levels in muscle to varying degrees (e.g. simultaneously trying to increase steroid hormone metabolism, decrease glucose metabolism) using cells in culture and observe the consequences on cellular metabolism. These experiments will help to guide our use of mice with genetically modified H6PDH and 11b-HSD1 genes, which will allow a true assessment of their roles in a more physiologically relevant system. The experiments will test how steroid hormones and glucose metabolism can be manipulated and derive the true function of these systems in helping to control muscle tissues energy requirements. Ultimately, we hope these basic and fundamental studies will help other scientists, pharmaceutical companies and medical practitioners to improve their scientific knowledge and research. Understanding how energy metabolism is controlled will also aid improvements society's knowledge and hopefully create future health benefits.</gtr:abstractText><gtr:technicalSummary>Mammalian carbohydrate homeostasis is of primary importance to energy provision and the action of insulin on metabolism. In muscle, glucose is phosphorylated to glucose-6-phosphate (G6P) and used by multiple pathways including ATP generation. We have identified the enzyme H6PDH, within the sarcoplasmic reticulum (SR) of muscle which can metabolise G6P and may have an important role in its utilisation. One known function of H6PDH is to generate NADPH cofactor which allows the enzyme 11b-HSD1 to produce intracellular glucocorticoids (GCs), hormones that control metabolism by regulating gene transcription. H6PDH knockout mice (H6PDHKO) show the obligate nature of 11b-HSD1 for H6PDH. In the absence of H6PDH, 11b-HSD1 inactivates GCs, leading to blunted responses to GCs. Interestingly H6PDHKO mice also develop a vacuolating myopathy associated with activation of ER stress pathways and alterations in local and global glucose homeostasis. We hypothesise that changes in muscle H6PDH expression can modulate G6P and ATP levels that affect local and whole body metabolism which can be independent of GCs and 11b-HSD1. Aims - Determine the contributions of H6PDH mediated G6P and GC metabolism to glucose homeostasis - Define the contribution of H6PDH G6P metabolism to myopathy and glucose homeostasis in H6PDKO mice - Elucidate the relationship between H6PDH expression in muscle and the ER stress response This study will define the metabolic role of H6PDH in muscle and how it relates to GC metabolism, insulin sensitivity and glucose homeostasis and explore the observations linking aberrant ER metabolism to defective muscle structure and function. The proposed research will determine new and fundamental mechanisms of carbohydrate metabolism in highly relevant systems that have important benefits for our understanding of mammalian metabolic physiology.</gtr:technicalSummary><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>908210</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>ChromaDex</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ChromaDex and Nicotinamide Riboside (NR) MTA</gtr:description><gtr:id>7D4188FE-F2B6-4010-AF9F-945D107C1396</gtr:id><gtr:impact>Has supported my research group being funded through the attainment of a Wellcome Trust Senior Research Fellowship- for which ChromaDex were a signed collaborator.</gtr:impact><gtr:outcomeId>5460e2753cf4a0.30530457-1</gtr:outcomeId><gtr:partnerContribution>ChromaDex have provided, under an MTA NR compound for use in experiments as described in the MTA.</gtr:partnerContribution><gtr:piContribution>Initiated collaboration as research indicated that Nicotinamide Riboside made by ChromaDex will have an important bearing on our results. We contacted them and we have entered an MTA to be supplied with NR compound.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>1x MRC/University of Birmingham studentships</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>56425F37-2C29-468D-8265-7E896C56509A</gtr:id><gtr:outcomeId>5460e82ea65db0.25818608</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3DDE06E5-C1BE-4662-B807-084429A38CB6</gtr:id><gtr:outcomeId>5460e722678f69.18473896</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1606529</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Research Fellowship In Basic Biomedical Sciecne</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>104612/Z/14/Z</gtr:fundingRef><gtr:id>FD513428-FBE0-4F47-8A57-4D5B2AE676B1</gtr:id><gtr:outcomeId>5460e3a54d7202.23911185</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>113000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2x MRC/University of Birmingham studentships</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>980470E5-999E-4BDD-BD6D-42C7EED02008</gtr:id><gtr:outcomeId>5460e82cea67c1.49757114</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>235000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>67A61883-0C55-4E8A-B7CF-07A7052C3596</gtr:id><gtr:outcomeId>5460e78e71e239.30323739</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Heath and well being treatment potential in a rare disease (Cushing's disease/ syndrome)- if the right centres and researchers wish to take these published findings forward in to clinical research then this could be very beneficial. New knowledge has been generated and can be used as the information base for new science to be conducted.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>C13D9324-EAB8-446D-80A8-E26C0004FB9A</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5460f56321d3d9.93205352</gtr:outcomeId><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Identified new systems that control muscle function in response to metabolic stress such as in obesity, diabetes, hormonal imbalance or other diseases. Clarified a key mechanism that may explain how an individual may succumb to glucocorticoid excess and suggest a therapeutic option.</gtr:description><gtr:exploitationPathways>Clinicians may which to use the data and resources we have generated to invest in trials examining the effectiveness of treatment options for Cushing's disease.</gtr:exploitationPathways><gtr:id>356A8415-8C78-4580-B6C4-43A3EC55AA0C</gtr:id><gtr:outcomeId>5460f45f152579.39055142</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Allows the tissue specific inspection of the function of the HSD11B1 gene in mice through genetic recombination methods.</gtr:description><gtr:id>7541740B-7767-420A-8633-4CD3DED6F2FA</gtr:id><gtr:impact>Supported successful grant and personal fellowship application and publications with translational implications for human health</gtr:impact><gtr:outcomeId>5460ea525c2706.25893880</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HSD11B1 floxed allele</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DAE44D15-DC1B-4E80-808B-BED735F9CB7F</gtr:id><gtr:title>Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11?-hydroxysteroid dehydrogenase type 1.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a440c1edea41fd8b10866dc9f79cdbc8"><gtr:id>a440c1edea41fd8b10866dc9f79cdbc8</gtr:id><gtr:otherNames>Lavery GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5460e0493dbf30.55964636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C8B5854-87B9-4229-BB0A-85E2523E7712</gtr:id><gtr:title>11?-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d98bf3954a69fc156c27af9fb0725e"><gtr:id>88d98bf3954a69fc156c27af9fb0725e</gtr:id><gtr:otherNames>Hardy RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>58be8633090572.07398668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D66AB0B-5E07-46F9-9540-E9C39D3CB91F</gtr:id><gtr:title>Cellular and genetic models of H6PDH and 11?-HSD1 function in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Cell biochemistry and function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c0c2146a1777df92fb9e61e7bcfd9fd"><gtr:id>8c0c2146a1777df92fb9e61e7bcfd9fd</gtr:id><gtr:otherNames>Zielinska AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0263-6484</gtr:issn><gtr:outcomeId>5a35126c5893a5.46118580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C2875F3-65A7-4EC4-A99B-F70B123BCFB2</gtr:id><gtr:title>Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoid.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/859f09d282ce557568df41587c35bd1a"><gtr:id>859f09d282ce557568df41587c35bd1a</gtr:id><gtr:otherNames>Soulier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5460e08aa4e362.42244850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2878171-F389-448D-8E99-61B2563079F8</gtr:id><gtr:title>11?-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50266dbb5bd134a51e37cc9434e56cf3"><gtr:id>50266dbb5bd134a51e37cc9434e56cf3</gtr:id><gtr:otherNames>Morgan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5460e0aea935f2.43865778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AAB47FF-DA9C-47EB-A9B4-FA8C627577DA</gtr:id><gtr:title>11?-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd3c2f45f3b8f27357013fb43d184259"><gtr:id>cd3c2f45f3b8f27357013fb43d184259</gtr:id><gtr:otherNames>Doig CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5a820fa3140ec7.06230233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD76A38C-90A6-4D18-9BD9-478DF654BC32</gtr:id><gtr:title>Male 11?-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74757ba33a4f5d12d4ab5eea50de0695"><gtr:id>74757ba33a4f5d12d4ab5eea50de0695</gtr:id><gtr:otherNames>Larner DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>58be8632759a91.67024440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC656111-E425-4D12-9E14-E40CAF7BF9E0</gtr:id><gtr:title>Glucocorticoids and 11?-HSD1 are major regulators of intramyocellular protein metabolism.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50266dbb5bd134a51e37cc9434e56cf3"><gtr:id>50266dbb5bd134a51e37cc9434e56cf3</gtr:id><gtr:otherNames>Morgan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>58be8632400868.12338917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F404444-45B1-4271-A5CC-A3E48DBFDB5A</gtr:id><gtr:title>11?-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.</gtr:title><gtr:parentPublicationTitle>Endocrine reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7416d802fac8c54a0a20f10e58737ab1"><gtr:id>7416d802fac8c54a0a20f10e58737ab1</gtr:id><gtr:otherNames>Gathercole LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0163-769X</gtr:issn><gtr:outcomeId>5460e084baa0f5.40361970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A8EF84-45C3-4D3D-99E4-014558096874</gtr:id><gtr:title>11?-Hydroxysteroid dehydrogenase-1 is involved in bile acid homeostasis by modulating fatty acid transport protein-5 in the liver of mice.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b76ffd129488a393ab0ed73a09a232d3"><gtr:id>b76ffd129488a393ab0ed73a09a232d3</gtr:id><gtr:otherNames>Penno CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>5460e0aecd8fd9.53787838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1EE016F-6EB3-4377-8077-A0E05B0A6B63</gtr:id><gtr:title>Regulation of lipid metabolism by glucocorticoids and 11?-HSD1 in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50266dbb5bd134a51e37cc9434e56cf3"><gtr:id>50266dbb5bd134a51e37cc9434e56cf3</gtr:id><gtr:otherNames>Morgan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5460e084e16641.64482246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>116E725D-9F3B-452F-92CE-CAE973C65795</gtr:id><gtr:title>Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11&amp;Icirc;&amp;sup2;-hydroxysteroid dehydrogenase type 1.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729e284d36dcb825ed1241f86b1599c1"><gtr:id>729e284d36dcb825ed1241f86b1599c1</gtr:id><gtr:otherNames>Semjonous NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5460dfefb52402.38850855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8532AA4-3DCD-497E-808D-D49DE4C5D72C</gtr:id><gtr:title>TNF&amp;Icirc;&amp;plusmn;-mediated Hsd11b1 binding of NF-&amp;Icirc;&amp;ordm;B p65 is associated with suppression of 11&amp;Icirc;&amp;sup2;-HSD1 in muscle.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd3c2f45f3b8f27357013fb43d184259"><gtr:id>cd3c2f45f3b8f27357013fb43d184259</gtr:id><gtr:otherNames>Doig CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5460e0ae84c6c3.68668207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A62F53-E9EC-45D1-9952-365E21F54E9E</gtr:id><gtr:title>Impaired oxidoreduction by 11&amp;Icirc;&amp;sup2;-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid.</gtr:title><gtr:parentPublicationTitle>Journal of lipid research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b76ffd129488a393ab0ed73a09a232d3"><gtr:id>b76ffd129488a393ab0ed73a09a232d3</gtr:id><gtr:otherNames>Penno CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2275</gtr:issn><gtr:outcomeId>5460e0855e32e3.59033917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A17CC35B-791D-43CE-B0DC-5B50D1924CDE</gtr:id><gtr:title>11?-Hydroxysteroid dehydrogenase type 1 contributes to the balance between 7-keto- and 7-hydroxy-oxysterols in vivo.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fda0d08dc05358633ab30fa85a1da75"><gtr:id>4fda0d08dc05358633ab30fa85a1da75</gtr:id><gtr:otherNames>Mitic T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>5460e0846c42b6.67055288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C13BB0A3-5004-4CC6-A710-03BC9427631A</gtr:id><gtr:title>Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11&amp;Icirc;&amp;sup2;-HSD1 and H6PDH.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f219ec830a488c1b7700f030ee78bf3"><gtr:id>9f219ec830a488c1b7700f030ee78bf3</gtr:id><gtr:otherNames>Abrahams L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5460e04967bac6.14533956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF54429-9129-460B-BF2D-1858947C20ED</gtr:id><gtr:title>11?-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14deda172184264b15fb9b1a046f4572"><gtr:id>14deda172184264b15fb9b1a046f4572</gtr:id><gtr:otherNames>Tiganescu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5460e08516a1d9.70931328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7963977-DD3F-4644-9D29-ABA9B8E7428F</gtr:id><gtr:title>Biochemistry and physiology of hexose-6-phosphate knockout mice.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c0c2146a1777df92fb9e61e7bcfd9fd"><gtr:id>8c0c2146a1777df92fb9e61e7bcfd9fd</gtr:id><gtr:otherNames>Zielinska AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>5460dfefd8f861.20634033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C386E7B-803A-40F9-B96D-30D2E4C790B9</gtr:id><gtr:title>Thymic function is maintained during Salmonella-induced atrophy and recovery.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5460e0498eadf3.90764720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC617FD8-7222-478C-A1F3-406AA646804C</gtr:id><gtr:title>Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/387842d227c2a593541673b0e609d2d3"><gtr:id>387842d227c2a593541673b0e609d2d3</gtr:id><gtr:otherNames>Lawson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5460e01d80e6d5.59741888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A77E51DD-B862-4824-88EE-A5E51212BCBD</gtr:id><gtr:title>11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50266dbb5bd134a51e37cc9434e56cf3"><gtr:id>50266dbb5bd134a51e37cc9434e56cf3</gtr:id><gtr:otherNames>Morgan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5460df99251f55.30013340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A10B4A9B-FFBC-44B4-8E0D-34EDE9B3351A</gtr:id><gtr:title>Premature adrenarche: novel lessons from early onset androgen excess.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59dd2557fd3beeb2639ff29bf8bdd2e"><gtr:id>a59dd2557fd3beeb2639ff29bf8bdd2e</gtr:id><gtr:otherNames>Idkowiak J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>5460e01da7e265.54365194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7045ABD8-51AD-477E-B317-60D8CE95D750</gtr:id><gtr:title>Carbonyl reduction of triadimefon by human and rodent 11&amp;Icirc;&amp;sup2;-hydroxysteroid dehydrogenase 1.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a2b3536d2fcb95f97c57606dc861ba"><gtr:id>35a2b3536d2fcb95f97c57606dc861ba</gtr:id><gtr:otherNames>Meyer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>5460e08492b8a0.48897378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FDD5B26-2BCE-4BFD-8A67-D7F1F6D420A7</gtr:id><gtr:title>Formation of threohydrobupropion from bupropion is dependent on 11&amp;Icirc;&amp;sup2;-hydroxysteroid dehydrogenase 1.</gtr:title><gtr:parentPublicationTitle>Drug metabolism and disposition: the biological fate of chemicals</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a2b3536d2fcb95f97c57606dc861ba"><gtr:id>35a2b3536d2fcb95f97c57606dc861ba</gtr:id><gtr:otherNames>Meyer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0090-9556</gtr:issn><gtr:outcomeId>5460e085391bf7.19859614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>763B642B-2AE1-47DD-9D03-D407B15839C6</gtr:id><gtr:title>MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50266dbb5bd134a51e37cc9434e56cf3"><gtr:id>50266dbb5bd134a51e37cc9434e56cf3</gtr:id><gtr:otherNames>Morgan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>58be8632a3dbe2.47792434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EA1424A-F896-424C-AC32-B79452AB82BD</gtr:id><gtr:title>Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS).</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137afff12d4533ad673529045e90711"><gtr:id>e137afff12d4533ad673529045e90711</gtr:id><gtr:otherNames>Krone N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>5460dfef8dde29.98875315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78A2A7CE-B64D-49CE-9E09-A52E13D0ECDD</gtr:id><gtr:title>Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a440c1edea41fd8b10866dc9f79cdbc8"><gtr:id>a440c1edea41fd8b10866dc9f79cdbc8</gtr:id><gtr:otherNames>Lavery GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>5460e08445e067.73789918</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G023468/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>